US drug regulator removes clinical hold on Novavax’s vaccines
Novovax Inc., will soon start enrollment for end-stage trials of its Covid-19-Influenza vaccine and stand-alone influenza jab following a nod from the US
Drugs
Health
Pharma
Drugs
Health
Pharma
AstraZeneca to invest $3.5 billion in the US to expand global footprint
Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of
Drugs
Health
Pharma
AbbVie says schizophrenic drug fails in 2 mid-stage experimental trials
AbbVie Inc.’s two mid-stage trials of an investigational schizophrenia drug have failed to meet its primary goal, according to a company statement.
Drugs
Health
Pharma
WHO to convene emergency meeting on mpox on November 22
The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency
Climate
Small nations at risk of climate change floodings despite least emissions
HQ Team November 11, 2024: A recent study led by the University of Bristol has revealed alarming insights into the vulnerability of Small
Health
Medical
Pharma
One stillbirth occurs worldwide every ten seconds: US public health body says
One stillbirth occurs every 10 seconds and one-third of these occur between 20 and 28 weeks gestation, according to data from the Institute for
Health
Medical
Pharma
Leed researchers find gut bacteria linked to rheumatoid arthritis
Rheumatoid arthritis may be associated with higher amounts of bacteria accumulating in the gut ten months before clinical diagnosis, researchers reveal.
Health
Medical
Pharma
Famine in Gaza Strip is ‘imminent,’ likelihood ‘substantial’: FRC
An international body of technical experts in the field of food security has issued an alert about an “imminent” and “substantial” likelihood of
Health
Rosuvastatin may lower mortality compared to atorvastatin: Study
HQ Team November 9, 2024: A recent study indicates that rosuvastatin is associated with a slightly reduced risk of all-cause mortality and major
Drugs
Health
Pharma
J&J seeks approval for its blood cancer therapy in US, European Union
Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood